[1] . Vaupel PW, et al:Cancer Res 1981, 41:2008.
[2] . Vaupel PW:Oxygen Supply to malignant tumors 1979, P.143, west palm Beach, CRC Press.
[3] . Adams GE, et al:Int 1 Radial Oncol Biol Phys 1986, 12:1299.
[4] . Hirst DG, et al:Br J Cancer 1987, 55:487.
[5] . Beddell CR, et al:Br J Pharmac 1984, 84:397.
[6] . Adams GE, et al:Some new developments in tumor radiosensitization, Proc. 3rd Int Meeting On Progress in Radio-oncology, March 27-30th 1985, Vienna, Austria.
[7] . Chan RC, et al:JNCI 1984, 72:145.
[8] . Knapp WH, et al:Int J Radiat Oncol Biol Phys 1985, 11:1357.
[9] . Chaplin DJ:Br J Cancer 1986, 54:727.
[10] . Chaplin DJ, et al:Int J Radiat Oncol Biol Phys 1987, 13:1357.
[11] . Voohees WD, et al:Vasodilator enhanced hypertherima therapy:A veterinary clinical study(Abstr. Bf-3)radiation research society meeting, 1986. Las Vcgas Nevada.
[12] . Chaplin DJ, et alt Int J Radiat Oncol Biol Phys 1986, 12:1091.
[13] . Jone GRN:Br J Cancer 1982, 45:638.
[14] . Jone GRN, et al:Med Hypotheses 1984, 15:349.
[15] . Rotin D, et al:Cancer Res 1986, 46:2821.
[16] . Leier CV, et al:Circulation 1881, 63:102.